Professor Matt Thompson

Chief Medical Officer @Endologix

[Endologix @endologix]

"These innovators revolutionized the treatment of abdominal aortic aneurysms, and we are proud to recognize the work they are doing to advance the field of vascular surgery.” --@MattThompsonCMO

Thanks to everyone who attended our EVAR Innovators Reception last night! #VEITH2018

[Professor Matt Thompson @MattThompsonCMO]

Join me for session 70 at 4:30pm to hear Dr. Kwolek's podium presentation on the latest results of the LEOPARD RCT study! #Veith2018

[Professor Matt Thompson @MattThompsonCMO]

Excited for a full day of EVAR talks tomorrow and then join us at 4:30pm for our Innovators Reception in the Clinton Suite of the Hilton Midtown. #Veith2018

[Professor Matt Thompson @MattThompsonCMO]

Dr. Nikols takes the podium today to discuss women with AAA. Session 44 at 3:05pm. And thank you to our EVAS2 Investigators for a great meeting this morning. #Veith2018

[Professor Matt Thompson @MattThompsonCMO]

Looking forward to an insightful podium talk from Dr. Minion on AAA Neck Dilatation - Session 5 today at 1:35 this afternoon! #Veith2018

[Professor Matt Thompson @MattThompsonCMO]

On Saturday at 1:30 hear Dr. Jennifer Ash present 1-year results from the LUCY Study, the first-ever prospective study to specifically evaluate EVAR in women #VAM18 #herEVARstory

[Professor Matt Thompson @MattThompsonCMO]

Thank you to all of the investigators who attended our EVAS2 User Experience Meeting at @VascularSVS #VAM18

[Professor Matt Thompson @MattThompsonCMO]

Join us Thursday June 21 at @VascularSVS as we dive into ENCORE, an analysis demonstrating durable 5-year EVAR outcomes. 5:30pm - Boston Sheraton #VAM18

[Professor Matt Thompson @MattThompsonCMO]

Congrats Kieran. Look forward to hearing much more about this https://t.co/2Zvtr9tAHY

[Professor Matt Thompson @MattThompsonCMO]

ENCORE, an analysis of 6 different Ovation studies being presented by Dr. Sean Lyden @CXSymposium. Thanks to all the clinical investigators who participated in the studies that are the basis for the ENCORE analysis #CX2018 #EVAR

[Professor Matt Thompson @MattThompsonCMO]

@endologix @CXSymposium Looking forward to this. Especially after great ENCORE data presented yesterday

[Professor Matt Thompson @MattThompsonCMO]

@NEJM @CXSymposium Great work from Alun and the team. Congratulations

[Professor Matt Thompson @MattThompsonCMO]

Excited to hear Late-Breaking Aortic Trial being presented on podium @CXSymposium by Dr. Marc Schermerhorn comparing EVAR and EVAS All-Cause Mortality #CX2018 #EVAS

[Professor Matt Thompson @MattThompsonCMO]

@jstelk @endologix @CXSymposium Looking forward to the great Endologix data today

[Professor Matt Thompson @MattThompsonCMO]

Dr. Jennifer Ash just presented @CXSymposium the Early Results of the LUCY Study, the first-ever prospective study to specifically evaluate EVAR in women #CX2018 #herevarstory

[Professor Matt Thompson @MattThompsonCMO]

Looking forward to seeing everyone @CXSymposium on Tuesday https://t.co/rl1JiOL76T #CX2018

[Professor Matt Thompson @MattThompsonCMO]

Hello Twitter! #myfirstTweet